CHF 29.65
(-0.17%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 320.37 Million EUR | 14.02% |
2022 | 280.97 Million EUR | -0.41% |
2021 | 282.12 Million EUR | 25.78% |
2020 | 224.29 Million EUR | 10.7% |
2019 | 202.61 Million EUR | 12.83% |
2018 | 179.57 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 FY | 320.37 Million EUR | 14.02% |
2023 Q4 | 188.53 Million EUR | 0.0% |
2023 Q2 | 131.83 Million EUR | 0.0% |
2022 Q4 | 147.32 Million EUR | 0.0% |
2022 Q2 | 133.65 Million EUR | 0.0% |
2022 FY | 280.97 Million EUR | -0.41% |
2021 FY | 282.12 Million EUR | 25.78% |
2021 Q2 | 135.13 Million EUR | 0.0% |
2021 Q4 | 146.99 Million EUR | 0.0% |
2020 Q4 | 135.86 Million EUR | 0.0% |
2020 FY | 224.29 Million EUR | 10.7% |
2020 Q2 | 88.42 Million EUR | 0.0% |
2019 Q3 | 50.65 Million EUR | 0.0% |
2019 FY | 202.61 Million EUR | 12.83% |
2019 Q4 | 50.65 Million EUR | 0.0% |
2019 Q2 | 50.65 Million EUR | 0.0% |
2019 Q1 | 50.65 Million EUR | 12.83% |
2018 Q1 | 44.89 Million EUR | 0.0% |
2018 Q2 | 44.89 Million EUR | 0.0% |
2018 Q3 | 44.89 Million EUR | 0.0% |
2018 Q4 | 44.89 Million EUR | 0.0% |
2018 FY | 179.57 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Kuros Biosciences AG | 33.56 Million CHF | -854.511% |